RxDoctor Payments Data
★ My doctorsLook up a doctor →

Amit Vijapura

Psychiatry · Jacksonville, FLNPI 1427152693

Payments from drug & device makers

$120,276in general payments, 2019–2025

Across 359 payments — averaging $335.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Idorsia Pharmaceuticals US Inc$38K
  • Otsuka America Pharmaceutical, Inc.$37K
  • Neurocrine Biosciences, Inc.$15K
  • Teva Pharmaceuticals USA, Inc.$9K
  • H. Lundbeck A S$8K
  • Ironshore Pharmaceuticals Inc.$5K
  • plus $8K from 24 others
$5,263in research payments, 2019–2025

Across 1 payment — averaging $5263.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • H. Lundbeck A S$5K

What the payments were for

  • Consulting fees$1,7502%
  • Speaking & faculty fees$99,12888%
  • Travel & lodging$4,9054%
  • Food & beverage$6,5786%
  • Education$590%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Idorsia Pharmaceuticals US Inc69$37,711
Otsuka America Pharmaceutical, Inc.65$37,130
Neurocrine Biosciences, Inc.32$15,155
Teva Pharmaceuticals USA, Inc.12$9,495
H. Lundbeck A S6$7,858
Ironshore Pharmaceuticals Inc.36$5,306
Takeda Pharmaceuticals U.S.A., Inc.21$2,228
Orexo US, Inc.7$1,871
Indivior Inc.10$975
Vanda Pharmaceuticals Inc.7$428
Axsome Therapeutics, Inc.4$273
Sunovion Pharmaceuticals Inc.9$264
Tris Pharma Inc7$230
AbbVie(2 entities)16$227
Lundbeck LLC11$201
Johnson & Johnson11$184
Avanir Pharmaceuticals, Inc.2$130
Neos Therapeutics, LP6$111
Corium, LLC7$108
Alkermes, Inc.4$74
Bausch Health US, LLC4$73
Neuronetics, Inc.2$46
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$43
Shire North American Group Inc2$33
Arbor Pharmaceuticals, Inc.2$29
Brainsway USA Inc1$28
E.r. Squibb & Sons, L.L.C.1$23
Almatica Pharma LLC1$16
Kaleo, Inc.1$15
Adlon Therapeutics L.p.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$120,276 in reported general payments places this provider in the 90th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine12$57,631
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl11$1,096
Ziprasidone Hcl13$230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$9,495$57,63112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Jacksonville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →